CVI Holdings’s Zura Bio ZURA Stock Holding History

CVI Holdings’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-22,800	Closed	-$233K	–	446
2022 Q4	$233K	Sell	22,800 -1,800	-7%	-$18.2K	0.03%	265
2022 Q3	$247K	Hold	24,600	–	–	0.02%	433
2022 Q2	$245K	Hold	24,600	–	–	0.02%	461
2022 Q1	$244K	Hold	24,600	–	–	0.02%	499
2021 Q4	$243K	Hold	24,600	–	–	0.02%	503
2021 Q3	$241K	Buy	+24,600	New	+$241K	0.02%	503

Other funds holding ZURA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SAMU

SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

CVI Holdings's ZURA Position: Q1 2023 in Review

CVI Holdings sold out of Zura Bio (ZURA) in Q1 2023, closing a stake of 22,800 shares — an estimated $233K sold.

CVI Holdings first reported a position in ZURA in Q3 2021 and held it in 6 quarters. The position peaked at $247K in Q3 2022. 3 funds tracked by Wall St. Rank hold ZURA as of Q1 2023.

CVI Holdings reported no remaining Zura Bio position as of Q1 2023 after selling out during the quarter.
CVI Holdings sold 22,800 Zura Bio shares in Q1 2023, an estimated $233K.
CVI Holdings first reported a position in Zura Bio in Q3 2021 and held it in 6 quarters.
CVI Holdings's Zura Bio position peaked at $247K in Q3 2022.
3 funds tracked by Wall St. Rank held Zura Bio as of Q1 2023.

Based on CVI Holdings's 13F filing for Q1 2023, filed 16 May 2023.